Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ADMP
FechaHoraFuenteTítuloSímboloCompañía
28/12/201818:46GlobeNewswire Inc.Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Tadalafil Sublingual TabletNASDAQ:ADMPAdamis Pharmaceuticals Corporation
18/12/201815:05Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/12/201815:30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/12/201808:30GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update on the U.S. Launch of SYMJEPINASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/11/201815:46GlobeNewswire Inc.Adamis Pharmaceuticals Announces Third Quarter 2018 Financial Results and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/11/201815:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/09/201815:05GlobeNewswire Inc.Adamis Pharmaceuticals Receives FDA Approval for Its Lower Dose Symjepi ProductNASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/08/201811:02GlobeNewswire Inc.Adamis Pharmaceuticals Provides Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
10/08/201808:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/08/201815:05GlobeNewswire Inc.Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in FullNASDAQ:ADMPAdamis Pharmaceuticals Corporation
03/08/201805:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
02/08/201808:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Pricing of Public Offering of Common StockNASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/08/201815:03GlobeNewswire Inc.Adamis Pharmaceuticals Announces Proposed Public Offering of Common StockNASDAQ:ADMPAdamis Pharmaceuticals Corporation
23/07/201808:00GlobeNewswire Inc.Adamis Pharmaceuticals Adds Sublingual Erectile Dysfunction Product Candidate to its PipelineNASDAQ:ADMPAdamis Pharmaceuticals Corporation
19/07/201805:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
18/07/201816:09Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
11/07/201815:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/07/201817:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/07/201819:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Distribution and Commercialization Agreement for SymjepiNASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/06/201815:48Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
10/05/201816:51GlobeNewswire Inc.Adamis Pharmaceuticals Announces First Quarter 2018 Financial Results and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
30/04/201817:21Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/03/201805:12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
15/03/201816:59GlobeNewswire Inc.Adamis Pharmaceuticals Discusses 2017 Highlights and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
08/03/201808:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Publication of a New Human Factors Study Comparing Its Symjepi™ Epinephrine Prefilled Syri...NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/03/201808:00GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update on Data Presented at the American Academy of Allergy, Asthma and Immunology (AAAAI) Jo...NASDAQ:ADMPAdamis Pharmaceuticals Corporation
23/02/201808:00GlobeNewswire Inc.Adamis Pharmaceuticals Updates Symjepi Commercialization PlansNASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/02/201813:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/02/201808:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces FDA Acceptance for Review for the  Supplemental New Drug Application of Its Low Dose Symjep...NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/12/201715:29GlobeNewswire Inc.US Compounding, a Subsidiary of Adamis Pharmaceuticals, Develops a Unique Compound to Manage Ulcers in HorsesNASDAQ:ADMPAdamis Pharmaceuticals Corporation
 Showing the most relevant articles for your search:NASDAQ:ADMP

Su Consulta Reciente

Delayed Upgrade Clock